Are you a life science business in Manchester that wants to explore opportunities to raise finance?
On Friday 23rd June, we are partnering with Deepbridge Capital, to provide dedicated “office hours” to entrepreneurs at any stage of the business lifecycle, looking to supercharge their growth . If this sounds like you, come and join a one-to-one session with Dr Savvas Neophytou, partner and head of Life Sciences at Deepbridge Capital. Savvas will be on hand to provide you with investment advice, support and help develop strategies to raise your finance.
Appointments times will be approximately 30 minutes. To book, please sign up and we will organise a session to suit you.
Sessions are hosted by investment partner Dr Savvas Neophytou, who is head of Life Sciences at Deepbridge Capital, specialists in funding life sciences and medical innovation. Savvas also co-founded Acorn Partners, a joint venture between Deepbridge Capital, Alder Hey Hospital and software engineers WeAreNova. He is a founding shareholder of a number of technology companies including Torafugu Tech and Cerneretec.
Torafugu is engaged in the emerging field of data driven enablers to improve health outcomes and Cerneretec is engaged in the development of point of care diagnostics for the acute care hospital setting. Savvas has also been CEO of Now Healthcare Group, an online doctor platform where he was part of the original team that set up Europe's largest telehealth platform.
Prior to that Savvas had a long career in the City, working for 15 years as an investment banker and ECM at JP Morgan, Bear Stearns, Shore Capital, Cantor Fitzgerald and Panmure Gordon. Sav holds a PhD in psychopharmacology from Nottingham University and a BSc (Hons) degree in pharmacology from Manchester University.